This invention relates to an accessory for attaching to a needle to prevent needle stick injuries. The safety needle accessory is suitable for use with a hollow needle and comprises a needle hub surrounding the needle and a slidable sleeve slidably mounted on the needle hub. The slidable sleeve bears resiliently on the needle hub such that, in use, as the slidable sleeve is caused to move into a retracted position. A restoring force is generated within the slidable sleeve and on removal of the needle from the patient the restoring force causes the slidable sleeve to move into an extended position covering the needle tip. The safety needle locks in this position after removal of the needle from the patient.
|
33. A safety needle attachment for surrounding a needle having a longitudinal axis, comprising:
a hub having a radially converging or diverging portion;
a sleeve having at least one cantilever arm, the sleeve configured to slide along the hub in an axial direction,
wherein the sleeve is slidable in a first axial direction between a first position for fully or substantially fully surrounding the needle with the sleeve, and a second position for exposing the needle,
wherein the at least one cantilever arm radially deforms upon sliding on the converging or diverging portion of the hub between the first and second positions, and
wherein the sleeve is further slidable in a second, opposite, axial direction between the second position and a third position for fully surrounding the needle by the sleeve; and
a restoring force generated by the radial deformation of the at least one cantilever arm for sliding the sleeve between the second and third positions.
1. A safety needle attachment for surrounding a needle having a longitudinal axis, comprising:
a hub;
a sleeve surrounding the hub and slidable along the hub in the axial direction;
wherein the sleeve has a radially elastically deformable portion, and the hub has a radially converging or diverging portion, and
wherein the sleeve is slidable in a first axial direction between a first position for fully or substantially fully surrounding the needle with the sleeve, and a second position for exposing the needle, wherein the converging or diverging portion of the hub causes elastic radial deformation of the deformable portion as the sleeve slides between the first and second positions, and wherein the sleeve is further slidable in a second, opposite, axial direction between the second position and a third position for fully surrounding the needle by the sleeve, the force for sliding between the second and third positions being provided by the stored elastic energy in the radially deformable portion.
34. A safety needle attachment for surrounding a needle having a longitudinal axis, comprising:
a hub having a radially converging or diverging portion;
a sleeve having:
a deformable portion, and
a circumambient spring operatively connected to the sleeve to elastically deform the deformable portion, the sleeve configured to slide along the hub in an axial direction,
wherein the sleeve is slidable in a first axial direction between a first position for fully or substantially fully surrounding the needle with the sleeve, and a second position for exposing the needle,
wherein the deformable portion radially deforms upon sliding on the converging or diverging portion of the hub between the first and second positions, and
wherein the sleeve is further slidable in a second, opposite, axial direction between the second position and a third position for fully surrounding the needle by the sleeve; and
a restoring force generated by the radial deformation of the deformable portion for sliding the sleeve between the second and third positions.
2. An attachment as claimed in
3. An attachment as claimed in
4. An attachment as claimed in
5. An attachment as claimed in
6. An attachment as claimed in
7. An attachment as claimed in
8. An attachment as claimed in
9. An attachment as claimed in
10. An attachment as claimed in
11. An attachment as claimed in
12. An attachment as claimed in
13. An attachment as claimed in
14. An attachment as claimed in
15. An attachment as claimed in
16. An attachment as claimed in
17. An attachment as claimed in
19. An attachment as claimed in
20. An attachment as claimed in
21. An attachment as claimed in
22. An attachment as claimed in
23. An attachment as claimed in
24. An attachment as claimed in
25. An attachment as claimed in
26. An attachment as claimed in
27. An attachment as claimed in
28. An attachment as claimed in
29. An attachment as claimed in
30. An attachment as claimed in
31. An attachment as claimed in
32. An attachment as claimed in
|
This application is a filing under 37 CFR 371 of PCT/GB2004/000516, filed Feb. 9, 2004, and claims priority from GB 0303026.9, filed Feb. 11, 2003, EP 03252192.4, filed Apr. 7, 2003 and GB 0327602.9, filed Nov. 27, 2003.
Needle stick injuries carry a significant risk of spreading infection, such as HIV and hepatitis, and are commonplace among healthcare workers. The USA has led the way in introducing legislation that obliges healthcare providers to use the safest devices when giving injections, intravenous drug administration and similar invasive procedures. Other countries are following and, even without legislation, the ever-present risk of litigation has alerted pharmaceutical companies and health authorities to seek suitable safe devices.
As a result of the heightened awareness of needle stick injuries, there have been a large number of inventions purporting to address this issue. Most take the form of a protective sleeve which covers the needle tip after the injection has been given, or means for retracting the needle rapidly into the syringe barrel. In the former case, a weakness of the designs has been the need for the user (i.e. the clinician) to perform an action to render the needle safe; thus if the step is omitted, the risk remains. Such a safety needle is exemplified by U.S. Pat. No. 4,911,693. In the latter case, the needle retraction mechanism requires that the syringe plunger is pushed to the end of its stroke in order to activate the retraction mechanism. In other words, virtually none of the devices are “fail safe”. In many real-life situations, the patient can involuntarily react to the pain of the injection and pull away from the needle, exposing the sharp tip, and therefore presenting a risk of a needle stick.
Another drawback of prior art safety needles (which in the present context includes safety syringes) is that they are not compatible with current accepted practice. The problems includes drug incompatibility with the device construction materials, difficulty in using standard sterilising methods, difficulty in fitting to the syringe, large size, difficulty in filling, and very high cost.
Again, a common requirement for drug administration is to draw the drug from a vial or bulk container, or first reconstitute a lyophilised drug, and then draw up the required volume of drug from the reconstitution vessel. Good practice demands that separate needles are used for such procedures, and from a practical viewpoint, the needle used to draw up the drug usually will be larger than the delivery needle. Most of the prior art devices do not address this aspect.
Another common requirement is for pre-filled syringes, and for reasons of drug compatibility and long-term storage, the syringe barrel is often made from glass, with the hypodermic needle bonded into the delivery end of the syringe barrel. Alternatively, a few drugs are compatible with plastics, and there are available plastic syringe barrels with moulded or bonded-in hypodermic needles.
Some safety devices have addressed the problems associated with manually operated safety sleeves, such as the devices disclosed in. U.S. Pat. Nos. 4,813,940 and 5,104,384. High cost has, however, tended to be a significant deterrent which has resulted in poor commercial success of the better devices. Potential specifiers and purchasers are put off by the high cost (several times that of a basic syringe), and have been able to cite the fallibility of the devices which are available as a way of avoiding buying them.
Again, there is a huge “inertia” in the world's healthcare system. The massive investment in manufacturing plants, aseptic production and assembly, sterilisation, existing long-term supply contracts, the bewildering number of so-called safety syringes on offer, and the drawbacks already noted, have mitigated against rapid adoption of safety needles and syringes.
There is therefore still a need for a low cost safety needle which prevents needle stick injuries in healthcare workers.
According to the invention, there is provided a safety needle attachment for surrounding a needle having a longitudinal axis, comprising:
This arrangement uses radial elastic deformation of a part of the sleeve to provide the return force for the sleeve. This avoids the need for a separate spring, and can enable the device to have a three-piece construction (hub, needle and sleeve). This dramatically reduces the manufacturing cost and complexity of the device when compared with prior art devices.
Preferably, a portion of the sleeve is elastically deformable radially outwardly as it rides over a radially diverging portion of the hub.
A latching arrangement can engage when the sleeve reaches the third position to prevent subsequent movement of the sleeve in the first axial direction.
An intermediate position mat be provided between the first and second positions of the sleeve, in which the sleeve is retained in position. The injection end of the needle can project partially from the sleeve in the intermediate position, so that alignment of the injection is facilitated.
The third position of the sleeve can be the same axially as the first position. In this case, wherein movement of the sleeve in the first axial direction causes rotation of the sleeve about the longitudinal axis. This then allows the sleeve to return to a different angular position to the starting position, so that an angularly positioned locking arrangement can be engaged.
In one embodiment, the radially converging or diverging portion of the hub comprises at least one recess for engaging with the deformable portion of the sleeve in a starting position of the sleeve, and otherwise has a substantially smooth outer surface.
This arrangement enables the sleeve to be held (axially and angularly) in the starting position, but once released the sleeve can rotate during the injection. This provides resistance to damage when subjected to external forces. Also, lateral forces are kept to a minimum.
The smooth outer surface can be conical, or polygonal in cross section perpendicular to the longitudinal axis. Thus “smooth” in intended to cover angled edges but with internal angles less than 180 degrees, so that the sleeve can ride over the edges rather than being trapped by them. The polygon may also have curved sides.
The starting position of the sleeve can cause the needle to project from the sleeve, and the attachment then preferably further comprises a cap.
In another version, tracks are used, and the radially converging or diverging portion of the hub comprises at least one track running the length of the hub, and a branch is provided to the track which defines a recess for engaging with the deformable portion of the sleeve in a starting position of the sleeve.
Again, the starting position of the sleeve can cause the needle to project from the sleeve, and the attachment then further comprises a cap.
The deformable portion of the sleeve preferably comprises a plurality of circumferentially spaced tines. There may be four such tines, by way of example.
The present invention also provides a safety needle, an injection device and a syringe incorporating the safety needle attachment as defined above. The safety needle comprises a hollow needle and the safety needle accessory as defined above, and the syringe comprises a piston, a barrel and the safety needle as defined above
The present invention further provides a method for injecting a patient using the safety needle as defined above.
The present invention will now be described with reference to the following drawings, in which:
In the drawings, like parts are given the same reference numerals.
The standard construction of a needle comprises a plastic needle hub which is tightly formed onto the needle (by moulding, gluing or thermal upsetting). The needle is protected by a plastic slidable sleeve which fits firmly but removably onto the needle hub. Normally the needle is packed in a pouch and the whole is sterilised, usually by gamma irradiation. Thus the typical needle comprises three parts, namely a hollow needle, a needle hub, and a removable sleeve.
The present invention may be conceptualised by comparing it with a conventional hypodermic needle: the component replacing the normal needle hub is one half of a returning mechanism, and the part that would be the protective slidable sleeve forms the other half of the mechanism, whilst also protecting the needle. Together with the needle, the component count is three, exactly the same as for a conventional hypodermic needle, and therefore a similar low manufacturing cost is achieved. Furthermore, the user does not have to learn a new technique, and so the adoption of the safety needle will not require special training of healthcare workers.
The cylindrical slidable sleeve 5 shrouds the needle 3 and the needle hub 7, and is freely sliding on and guided by the needle hub 7. At the receiving end (i.e. the syringe end) of slidable sleeve 5, there are four cantilever arms 9 which bear resiliently upon the surface of the conical section 18. The slidable sleeve 5 is free to slide on the needle hub 7, but is temporarily prevented from doing so by the locking ring 13. Locking ring 13 is moulded integrally with the slidable sleeve 5 by a frangible joint 15, and may be partially or wholly detached by pulling on the tab 14 to break the frangible joint 15. It is preferred that the ring 13 remains attached to the slidable sleeve 5 to reduce the number of discarded parts. In addition, the frangible joint provides a tamper-evident lock. Alternatively, the locking ring 13 may be moulded to the needle hub 7 via a suitable frangible connection. When the locking ring 15 is removed, as shown in
As shown in
Although the surface 18 is exemplified by a conical surface, other embodiments may be used within the scope of the present invention. In the Figures the surface is straight, i.e. substantially conical (namely sufficiently conical to generate a restoring force). However, the surface need not be straight as shown, but may be curved to give a more linear return rate. Thus the force Y could be substantially constant over a reasonable working stroke of the slidable sleeve 5. In addition, the whole surface 18 of the receiving end of the needle hub 17 need not be conical. In fact just one tapered section, e.g. a tapered ridge, would be sufficient. The tapered section does not have to project from the surface of the needle hub 7. The tapered section could also descend into the wall of the needle hub, i.e. a tapered detent rather than a tapered ridge. Also, as described below with reference to
These different arrangements provide a great deal of design flexibility in the safety needle accessory of the present invention. For example, the linearity of the return rate may be varied depending on the particular requirements for a particular application.
The way the sleeve is retracted and then returns to a safe position has been described above. A mechanism is also preferably provided for locking the sleeve in the safe position, and this mechanism is described with reference to
When the slidable sleeve 5 returns in direction Y, it travels slightly past its original staring position, so that a resilient pawl 20 shown in
In this design, there are therefore three operative positions of the sleeve—the starting position, the injection position and the safety position.
In the starting position (a first extended position), the slidable sleeve is able to be moved towards the receiving end of the needle hub and in the safety position (a second extended position) the slidable sleeve is in a locked position.
The different start and finish positions of the slidable sleeve 5 are determined by a detent mechanism shown in
The sleeve has a pin 10 projecting from an inner surface of the sleeve housing and this projects into a chamber within the hub 7.
The coupling is arranged so that after the first two or three millimeters of movement of the sleeve, the pin 10 triggers a switching operation by tripping a latching pawl, so that the slidable sleeve returns only to the safety position.
In the initial assembly of the safety needle, the slidable sleeve 5 is placed over the needle 3 with pin 10 proximate to a tab 26 formed as part of the needle hub 7 at position a. As the slidable sleeve 5 is moved further, the pin 10 deflects a resilient pawl 19, until the pin 10 is trapped behind tab 26 at position b. In this position, the slidable sleeve 5 is trapped on the needle hub 7 and cannot be removed without applying considerable force. This is the position of the components as supplied to the end user, and the location of the locking ring 13 takes account of this.
With the locking ring 13 removed, the slidable sleeve 5 is pushed further towards the syringe 2, and pin 10 again deflects the resilient pawl 19 until the pin 10 reaches position c. This distance i defines the initial displacement of the slidable sleeve 5, when starting the injection, and the tip of needle 3 may be level with the face 6 of slidable sleeve 5. The slidable sleeve 5 may now be moved towards the syringe until the pin 10 reaches the end wall 28 of the chamber 27 at position d. This position defines the maximum displacement of slidable sleeve 5, and thus the maximum exposure of the needle 3.
At any time, if the force acting on slidable sleeve 5 is removed, the slidable sleeve 5 will return in the direction of arrow Y until pin 10 reaches the position e. This is the safety position, and has the sleeve slightly further extended than in the starting position (b). Pin 10 would also help, prevent the removal of slidable sleeve 5, but additionally a tooth 21 on the outside of the hub 7 is now proximate to an internal face 22 on a cantilever arm 9, which prevents the removal of the slidable sleeve 5.
In this final position, a pawl 20 on the inside surface of the sleeve 5 engages with end face 16 of the hub 7 and prevents the slidable sleeve 5 from being moved. It should be noted that with the present diagrammatic presentation of the safety needle, a small amount of rotational movement is necessary between the slidable sleeve 5 and hub 7 to permit the pin 10 to move from position c to position e, but the rotation is preferably negligible.
The tab 26, resilient pawl 19, and chamber 27 are moulded integrally with the needle hub 7, and the pin 10 extends into the chamber and is allowed to move freely except where controlled by the detent and the boundaries of the chamber.
The detent mechanism is interchangeable between the slidable sleeve 5 and needle hub 7 if required. Also, the detent mechanism described hereinabove is but one of a number of such mechanisms, the main requirement being to permit the following sequence of operation: permit the slidable sleeve to be moved sufficiently so that the opening in the slidable sleeve is level with or just in front of the needle tip, at which position the detent must be activated so that if the displacing force on the slidable sleeve is removed, the slidable sleeve slides forward and locks, thus protecting the user from contact with the needle tip. Typically, the tip of the needle would be about 3 mm back from the face of the opening in the slidable sleeve at the start, and 1 mm back from the face when the detent is activated.
As an alternative to being supplied pre-assembled, the safety needle accessory may be supplied without a needle and then the accessory is attached to an injection device having an integral needle.
Alternatively, a more defined snap-fitting termination may be formed, the object being to make the device 1 difficult to remove after assembling it to the syringe barrel.
The examples above use a chamber and pin, formed as part of the sleeve, to define the different operative positions of the sleeve. It is instead possible to use the cantilever arms 9 themselves to determine the operative positions as well as to provide the restoring force.
Thus, the needle hub and the slidable sleeve are adapted to allow the slidable sleeve to be retracted into and held at an intermediate position between the extended position and the retracted position such that, in use, the injection end of the needle 2 projects partially from the slidable sleeve, that is the needle bevel is exposed but the needle is not sufficiently exposed to the extent that the needle may be inserted into the patient. In the intermediate position the locking mechanism is not engaged and hence the slidable sleeve may be retracted further into the (fully) retracted position as it is inserted into the patient. The advantages of this arrangement are that exposing the tip of the needle partially allows the user to position the needle more precisely on, for example, the patient's skin, and also facilitates the aspiration of trapped air and excess drug.
In the position shown in
The hub 7 has a track 7a for each cantilever arm which runs the length of the hub. At the top of the track 7a is a recess 7b, and this defines the safety position as will become apparent below. Initially, the sleeve has an angular orientation which means the arms 9 are not aligned with the track 7a.
Referring to
Referring to
At the end of travel towards the safety position, the projections 33 on cantilever arms 5 drop into the hole 41 as shown in
In the example above, the angular orientation of the sleeve needs to be correct initially, so that the at least one of the arms 9 follows a path to the latch 35. This can be achieved using a second groove/track 50 as shown in
In the examples above, the needle is supplied to the user with the needle covered by the sleeve. As mentioned above, it may be desirable to provide an intermediate locked position.
An alternative way to achieve this is to supply the needle to the user in the intermediate position, but with a protective cover. This cover can then engage with the hub, for example the tabs at the base of the hub shown in
The locking of the sleeve in the safety position is also achieved in a different manner. When the sleeve reaches the fully extended position, the arms drop out of the track 40 and engage over a hub/head 56. This means the sleeve can rotate when in the safe position. This is an advantage, as locking the rotation of the sleeve can result in the sleeve deforming when subjected to a lateral force or torque, increasing the possibility of damage or danger.
The example of
The hub 7 shown in
A cam surface 74 deflects the sleeve 5 rotationally as the arms are pushed out of the recess 70. The arms, and therefore the sleeve, can then rotate as the injection takes place. When the sleeve returns towards the safety position of
In the same way as described above, the arms engage over hub/head 56 when in the safety position shown in
As each face of the octagon has the lowest radius in the centre, the arms will be very lightly biased towards the centre. This bias force is much less than the lateral forces which can be encountered when engaging with a track, but further help to reduce the probability that the cam surfaces will be contacted on the return path of the sleeve.
This effect is exaggerated in the design of
Importantly, the cost of the components of the present invention in all embodiments, as well as the assembly costs will be of the same order as those for a conventional needle.
It is preferable that the coefficient of friction between the slidable sleeve 5 and the needle hub 7 is low, so that the resultant biasing force to return the slidable sleeve is not compromised by “stiction”, or so high that the force required on the patient's skin to deflect the slidable sleeve 5 is excessive. This may be achieved by careful selection of materials. Such materials are known in the art, for example, the needle hub could be made from a high-density polyethylene or similar drug-compatible plastics material, and the slidable sleeve from an inexpensive plastics material such as polycarbonate, polystyrene, polyester or PVC. A more expensive, highly creep-resistant plastics material, for example polyphenylene sulfone, could also be used.
As an alternative, the slidable sleeve, or just the at least one cantilever arm, may be made from metal, preferably stainless steel. The metal would be fabricated sufficiently thinly to provide the required elastic properties.
The example of
If necessary, a lubricant may be used, or a lubricant may be incorporated with polymers. Generally the materials should be suitable for sterilisation by gamma radiation, but it is possible to select materials compatible with sterilisation by steam or other gas such as ethylene oxide.
In some embodiments, the slidable sleeve, prior to use, is not under any substantial load. Any substantial load indicates a load which is sufficient to cause the material of the slidable sleeve to undergo creepage during storage at ambient temperature.
In the examples where the device is supplied in the intermediate position, there will be a preload. This may make the use of a metal sleeve preferable.
Thus the procedure for using the safety needle is the same as with using conventional needles. Where a locking ring is used, the act of releasing the locking ring is similar to removing the temporarily captive needle cover from a conventional needle. Of course, where a cap is used, this is similar to conventional needle use.
The safety needle 1 may be supplied pre-assembled as shown in
In the examples above, the arms are caused to diverge radially as the injection is carried out. Instead, the arms can follow a converging path defined by the hub, and the same elastic restoring force can be generated in this way.
In some examples above the starting point for the sleeve is with a short length of needle exposed. The term “substantially fully surrounding” in respect of the sleeve is intended to cover this configuration in this description and claims.
As an alternative to the tapered outer surface of the needle hub 7, to provide radial expansion/compression of the arms, the slidable sleeve can have at least one cantilever arm which engages a helical track in the outer surface of the needle hub such that, in use, as the needle is inserted into a patient, the at least one cantilever arm is displaced radially by the helical track in the outer surface of the needle hub thereby generating the restoring force. Thus, as the slidable sleeve 5 is caused to move towards the receiving end of the needle hub 7, one or more cantilever arms 9 are forced to follow the direction of the helical tracks. Since the cantilever arms 9 are resilient, a restoring force will be generated.
As an alternative to cantilever arms, the receiving end of the slidable sleeve itself may have elastic properties such that, in use, as the needle is inserted into a patient, the restoring force is generated within the slidable sleeve. Thus, the restoring force can be generated within a radially continuous slidable sleeve, i.e. a sleeve without cantilever arms. The elastic properties may be achieved by using an elastic material, such as an elastomeric polymer. Alternatively, the receiving end of the slidable sleeve may be concertinaed, with the ridges, of course, running parallel to the hollow needle. The elastic properties could also be generated using a circumambient spring attached to the slidable sleeve.
As previously mentioned hereinabove, the syringe may be supplied empty or pre-filled. When a pre-filled syringe is used, the syringe is preferably sealed using a sealing cap or plug to prevent evaporation or loss of the drug, excipient, carrier and/or diluent by, for example, thermal expansion.
As well as application to a syringe, the same safety needle accessory described herein could form the basis of a intravenous giving set, so that the insertion of the needle into the patient's vein is simple and safe. Indeed, the safety needle accessory of the present invention may be used with any suitable injection device.
Other modifications of the present invention will be apparent to those skilled in the art.
Weston, Terence Edward, Emmott, Douglas Arthur
Patent | Priority | Assignee | Title |
10751479, | Oct 08 2014 | Carebay Europe Ltd | Needle cover assembly |
Patent | Priority | Assignee | Title |
1845036, | |||
3114455, | |||
3134380, | |||
3677245, | |||
4553541, | Mar 23 1981 | Becton, Dickinson and Co. | Automatic retractable lancet assembly |
4795432, | Feb 19 1987 | Shield assembly for hypodermic injection devices | |
4813940, | Nov 19 1986 | NMT Group PLC | Injection devices |
4850996, | Feb 22 1988 | Safety needle | |
4911693, | Oct 17 1988 | Hypodermic syringe needle guard | |
4927019, | Jun 12 1989 | HABLEY MEDICAL TECHNOLOGY CORPORATION, 22982 ALCALDE, LAGUNA HILLS, CA 92653, A CA CORP | Combination needle sheath and sterility package |
5015240, | May 01 1990 | Ian Campbell, Cree; CREE, IAN CAMPBELL, | Hypodermic needle shield |
5104384, | Oct 05 1988 | NMT Group PLC | Injection devices |
5219339, | Nov 17 1989 | Single use medical needle | |
5242401, | Oct 09 1992 | Disposable needle head assembly | |
5312366, | Nov 16 1992 | Shielded cannula assembly | |
5336197, | Mar 10 1992 | InjectiMed, Inc. | Hard cover for protected injection apparatus |
5385561, | Jan 18 1994 | Bard International, Inc.; C R BARD, INC | Apparatus and method for injecting a viscous material into the tissue of a patient |
5421347, | May 07 1991 | CCS, CLEAN CHEMICAL SWEDEN AB | Disposable lancet device for puncturing skin |
5549568, | Aug 22 1994 | Elastomeric needle shield and hub-cap | |
5601535, | Jul 29 1985 | British Technology Group Ltd. | Safety device for hypodermic needle or the like |
5658256, | Aug 22 1994 | Universal sharps shield | |
5669888, | Jan 31 1994 | MATEF | Injection needle protection device |
5755696, | Jun 30 1997 | Becton, Dickinson and Company | Syringe filling and delivery device |
5891103, | Sep 23 1994 | Becton Dickinson and Company | Shielded needle assembly |
5910130, | Sep 26 1996 | Becton, Dickinson and Company | Shield and actuator for needles |
5944699, | Aug 11 1997 | BECTON DICKINSON FRANCE, S A | Pre-assembled syringe |
5971966, | Jul 19 1994 | Novo Nordisk A/S | Needle magazine |
6203529, | Nov 19 1997 | Haselmeier GmbH; Sanofi-Aventis Deutschland GmbH | Needle arrangement |
6210374, | Apr 20 2000 | U S SAFETY SYRINGES CO , INC | Needle protective sheath device |
6261264, | Jul 23 1999 | BIOPROTECTIVE TECHNOLOGIES, L L C | Safety cap assembly for needles |
6331174, | Oct 27 1994 | SCHOTT AG | Prefilled, low particle, sterile disposable syringe for injecting preparations and procedure for manufacture |
6398762, | Dec 05 1998 | Arzneimittel GmbH Apotheker Vetter & Co. Ravensburg | Syringe needle protector |
6511460, | Aug 07 1998 | Tech Group Europe Limited | Injection syringe with externally mobile needle shield |
6537259, | Mar 07 2000 | Becton Dickinson and Company | Passive safety device |
6685676, | Apr 17 1998 | Becton Dickinson and Company | Safety shield system for prefilled syringes |
7041086, | Dec 12 2002 | Safety syringe needle | |
7182734, | Aug 09 2001 | Becton Dickinson and Company | Retracting needle safety device |
7223258, | Aug 28 1998 | Becton Dickinson and Company | Safety shield assembly |
20020004648, | |||
20020087180, | |||
20030014018, | |||
20030144633, | |||
20040116877, | |||
20040210196, | |||
20050038391, | |||
20060129173, | |||
20060167411, | |||
20080183140, | |||
CN1777453, | |||
EP467173, | |||
EP744183, | |||
EP815884, | |||
EP1252907, | |||
EP1447108, | |||
EP1535640, | |||
EP1558311, | |||
FR2701848, | |||
JP3158171, | |||
WO176665, | |||
WO191837, | |||
WO2006090118, | |||
WO2089878, | |||
WO2100467, | |||
WO3066141, | |||
WO2004000397, | |||
WO20040171560, | |||
WO2004069302, | |||
WO2006082350, | |||
WO2008067467, | |||
WO9111212, | |||
WO9400172, | |||
WO9419036, | |||
WO176665, | |||
WO2004071560, | |||
WO9111212, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Feb 09 2004 | Salvus Technology Limited | (assignment on the face of the patent) | / | |||
Jan 16 2006 | WESTON, TERENCE EDWARD | Salvus Technology Limited | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 017270 | /0173 | |
Jan 16 2006 | EMMOTT, DOUGLAS ARTHUR | Salvus Technology Limited | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 017270 | /0173 | |
Sep 16 2020 | SALVUS TECHNOLOGY LTD | WEST PHARMACEUTICAL SERVICES, INC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 054087 | /0370 |
Date | Maintenance Fee Events |
Apr 11 2016 | M1551: Payment of Maintenance Fee, 4th Year, Large Entity. |
Apr 09 2020 | M1552: Payment of Maintenance Fee, 8th Year, Large Entity. |
Apr 09 2024 | M1553: Payment of Maintenance Fee, 12th Year, Large Entity. |
Date | Maintenance Schedule |
Oct 09 2015 | 4 years fee payment window open |
Apr 09 2016 | 6 months grace period start (w surcharge) |
Oct 09 2016 | patent expiry (for year 4) |
Oct 09 2018 | 2 years to revive unintentionally abandoned end. (for year 4) |
Oct 09 2019 | 8 years fee payment window open |
Apr 09 2020 | 6 months grace period start (w surcharge) |
Oct 09 2020 | patent expiry (for year 8) |
Oct 09 2022 | 2 years to revive unintentionally abandoned end. (for year 8) |
Oct 09 2023 | 12 years fee payment window open |
Apr 09 2024 | 6 months grace period start (w surcharge) |
Oct 09 2024 | patent expiry (for year 12) |
Oct 09 2026 | 2 years to revive unintentionally abandoned end. (for year 12) |